Blake, D. R., Vaseva, A. V., Hodge, R. G., Kline, M. P., Gilbert, T. S., Tyagi, V., . . . Der, C. J. (2019). Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer. Sci Signal.
Chicago-tyylinen lähdeviittausBlake, Devon R., et al. "Application of a MYC Degradation Screen Identifies Sensitivity to CDK9 Inhibitors in KRAS-mutant Pancreatic Cancer." Sci Signal 2019.
MLA-viiteBlake, Devon R., et al. "Application of a MYC Degradation Screen Identifies Sensitivity to CDK9 Inhibitors in KRAS-mutant Pancreatic Cancer." Sci Signal 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.